Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CAT off on failed Trabio Phase II/III

Cambridge Antibody (LSE:CAT; CATG) was off $1.41 (11%) to $11.34 on

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE